PartnerRe Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

PartnerRe Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-11,276	Closed	-$720K	–	59
2016 Q1	$720K	Buy	11,276 +100	+0.9%	+$6.31K	0.37%	44
2015 Q4	$769K	Sell	11,176 -19,003	-63%	-$1.26M	0.4%	40
2015 Q3	$1.79M	Buy	30,179 +68	+0.2%	+$4.31K	0.3%	54
2015 Q2	$2M	Sell	30,111 -5,104	-14%	-$336K	0.38%	54
2015 Q1	$2.27M	Sell	35,215 -112	-0.3%	-$7.01K	0.38%	52
2014 Q4	$2.08M	Buy	35,327 +4,985	+16%	+$281K	0.34%	55
2014 Q3	$1.55M	Sell	30,342 -4,894	-14%	-$244K	0.31%	62
2014 Q2	$1.71M	Sell	35,236 -4,496	-11%	-$222K	0.3%	63
2014 Q1	$2.06M	Buy	39,732 +96	+0.2%	+$5.11K	0.35%	57
2013 Q4	$2.11M	Sell	39,636 -2,324	-6%	-$118K	0.36%	55
2013 Q3	$1.94M	Sell	41,960 -5,435	-11%	-$239K	0.33%	58
2013 Q2	$2.12M	Buy	+47,395	New	+$2.06M	0.34%	54

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

PartnerRe Asset Management's BMY Position: Q2 2016 in Review

PartnerRe Asset Management sold out of Bristol-Myers Squibb (BMY) in Q2 2016, closing a stake of 11,276 shares — an estimated $720K sold.

PartnerRe Asset Management first reported a position in BMY in Q2 2013 and held it in 12 quarters. The position peaked at $2.27M in Q1 2015. 1,576 funds tracked by Wall St. Rank hold BMY as of Q2 2016.

PartnerRe Asset Management reported no remaining Bristol-Myers Squibb position as of Q2 2016 after selling out during the quarter.
PartnerRe Asset Management sold 11,276 Bristol-Myers Squibb shares in Q2 2016, an estimated $720K.
PartnerRe Asset Management first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 12 quarters.
PartnerRe Asset Management's Bristol-Myers Squibb position peaked at $2.27M in Q1 2015.
1,576 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2016.

Based on PartnerRe Asset Management's 13F filing for Q2 2016, filed 14 Jul 2016.